GlassScriptPhysician profile
Joseph A Cambio
NPI 1558428540
$11,099.51
in general payments reported to CMS, 2019-2025
39 companies · $2,121 in 2025
The $2,121 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $513 · 2021: $810 · 2022: $2,159 · 2023: $2,718 · 2024: $1,875 · 2025: $2,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,039 · Travel and Lodging: $1,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,038.83 |
| Travel and Lodging | $1,675.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $4,025.40 | 2021-2025 | Urolift, Barrigel |
| Procept Biorobotics Corporation | $2,028.18 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
| Axonics, INC. | $1,134.90 | 2021-2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $681.81 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Neotract INC. | $659.34 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $437.51 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $410.50 | 2019-2025 | Lupron Depot |
| Boston Scientific Corporation | $142.42 | 2019-2023 | Ams 700 Cxr Rte Kit |
| Janssen Biotech, INC. | $131.68 | 2019-2025 | Erleada |
| Pfizer INC. | $123.59 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $104.15 | 2019-2022 | |
| Endo USA, INC. | $97.36 | 2025 | Aveed, Xiaflex |
| Antares Pharma, INC. | $89.37 | 2021-2024 | Xyosted |
| Progenics Pharmaceuticals, INC. | $77.77 | 2023-2025 | Pylarify |
| Immunitybio, INC. | $75.05 | 2025 |
Show all 38 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cambio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.